PubMed Health⌕ Search

PubMed · 1316375

New simple method for thyroid volume determination by ultrasonography.

Abstract

A new, simple, and accurate ultrasonic method is elaborated for thyroid volume determination with commercially available high-resolution real-time equipment. The method takes into account the special and variable shape of the thyroid. The measurements were taken in three perpendicular sections. Volume calculations were done by applying the corrected ellipsoid model and computer-aided numerical integration, as well as by the conventional simple ellipsoid model. The accuracy of the method was tested by comparing direct measurements of a silicone rubber phantom with ultrasonography of a tissue-equivalent thyroid phantom. Both phantoms were modeled as casts of the same thyroid, which was obtained at autopsy. From the phantom measurements the deviation between the volume calculated by numerical integration or the corrected ellipsoid method and the real volume determined directly with the silicone rubber phantom was less than 5% on average, while volume calculations using the conventional ellipsoid model involved about +20% systematic error. In vivo studies in 40 subjects gave similar results: the ratios of the volumes calculated by simple and corrected ellipsoid method and by numerical integration [V(E), V(CE), and V(NI), respectively] were [V(E)/V(CE)] = 1.19 +/- 0.11 and [V(NI)/V(CE)] = 1.02 +/- 0.11. In conclusion corrected ellipsoid method is suggested for the clinical practice.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Szebeni, E Beleznay. 1992. New simple method for thyroid volume determination by ultrasonography.. https://doi.org/10.1002/jcu.1870200505

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗